The global alpha 1 antitrypsin deficiency treatment market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028. More Info:- https://www.imarcgroup.com/alpha-1-antitrypsin-deficiency-treatment-market